Moderna Spikevax COVID-19 Vaccine from Germany
Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit immune response. As a biotechnologically produced immunological product in pre-filled syringes for retail sale, it fits HTS 3002.15.00.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Maintain -70°C ultra-cold chain with validated shipping containers and temperature logs
• Submit IND or BLA documentation; declare as finished dosage form
• Beware expiry date issues leading to waste pharma classification under 3006.92